ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pain"

  • Abstract Number: 2692 • 2015 ACR/ARHP Annual Meeting

    The Patients Evaluation of Pain and Disease Activity As Well As Improvement during One-Year Follow-up on Etanercept Treatment Is Highly Associated to Subjective Factors and Not to Objective Assessments Including Ultrasound

    Hilde Berner Hammer1 and Jon Lampa2, 1Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Dep of Medicine, Rheumatology unit, Karolinska Institute, Karolinska Institute, Stockholm, Sweden

    Background/Purpose: Patient reported outcomes (PROs) are important for evaluation of treatment response in patients with rheumatoid arthritis (RA). Ultrasound (US) is a sensitive method for…
  • Abstract Number: 259 • 2014 ACR/ARHP Annual Meeting

    Development of Pediatric Item Banks to Measure Pain Behavior in the Patient Reported Outcomes Measurement Information System

    Esi M. Morgan DeWitt1, Kimberly Barnett2, Wen-Hung Chen3, Jennifer Farrell4, Dennis Revicki5, Adam Carle6, Karon Cook7, Kenneth Goldschneider8, Carlton Dampier9, David D. Sherry10 and Susmita Kashikar-Zuck2, 1Department of Pediatrics, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Evidera, Bethesda, MD, 4Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Outcomes Research, Evidera, Bethesda, MD, 6Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7Center for Patient-Centered Outcomes - Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 8Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 9Department of Pediatrics (Hematology-Oncology), Emory University School of Medicine, Atlanta, GA, 10Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose The NIH Patient Reported Outcomes Measurement Information System (PROMIS) has created publicly available patient reported outcomes measures in several domains of physical, social and…
  • Abstract Number: 255 • 2014 ACR/ARHP Annual Meeting

    Pain As Predictor of Organ Involvement in Fabry Disease

    Pierre Kaminsky1, Frederic Barbey2, Roland Jaussaud3, Francis Gaches4, Vanessa Leguy-Seguin5, Eric Hachulla6, Thierry Zenone7, Christian Lavigne8, Claire Douillard9, Isabelle Marie10, Boris Bienvenu11, Bertrand Dussol12 and Olivier Lidove13, 1Internal Medicine, CHU Nancy, Vandoeuvre, France, 2CHU Vaudois, Lausanne, Switzerland, 3CHU de Reims, Reims, France, 4Hôpital Ducuing, Toulouse, France, 5CHU Dijon, Dijon, France, 6Medicine Interne et Oncologie Medicale Centre Pole, Lille University, Lille, France, 7CH de Valence, Valence, France, 8CHU d'Angers, Angers, France, 9CHU Lille, Lille, France, 10CHU de Rouen, Rouen, France, 11Médecine interne, CHU Côte de Nacre, CAEN, France, 12AP Marseille, Marseille, France, 13Médecine interne, Hôpital Croix-Saint-Simon, PARIS, France

    Background/Purpose Fabry disease (FD) in a X-linked hereditary lysosomal disorder due to alphagalactosidase A deficiency, leading to the accumulation of its substrate (globotriaosylceramide) in vessels,…
  • Abstract Number: 254 • 2014 ACR/ARHP Annual Meeting

    The Effect of Milnacipran on Pain in Rheumatoid Arthritis Patients with Widespread Pain:  a Randomized Blinded Crossover Trial

    Yvonne C. Lee1, Elena Massarotti2, Robert R. Edwards3, Bing Lu4, Chih-Chin Liu5, Yuanyu Lo4, Alyssa Wohlfahrt4, Nancy Kim6, Daniel J. Clauw7 and Daniel H. Solomon8, 1Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Rheumatology/PBB-3, Brigham & Women's Hosp, Boston, MA, 3Anesthesiology, Brigham & Womens Hospital, Chestnut Hill, MA, 4Brigham and Women's Hospital, Boston, MA, 5Rheumatology & Immunology, Brigham & Women's Hospital, Boston, MA, 6Div of Rheumatology, Massachusetts General Hospital, Charlestown, MA, 7Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, 8Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Clinical trials have shown that serotonin norepinephrine reuptake inhibitors, such as milnacipran, decrease pain in chronic non-inflammatory pain conditions like fibromyalgia and osteoarthritis. We…
  • Abstract Number: 144 • 2014 ACR/ARHP Annual Meeting

    Sonographic Differentiation of Heel Pain: Focal Degenerative Versus Systemic Inflammatory Enthesitis

    Patrick Hook1, Diana Vradii2, Maureen Dubreuil3,4, Hau Pham5 and Eugene Y. Kissin1, 1Rheumatology, Boston University School of Medicine, Boston, MA, 2Rheumatology, Mid Coast Hospital Medical Center, Brunswick, ME, 3Rheumatology, Boston University Medical Center, Boston, MA, 4Rheumatology, Boston VA HealthCare System, Boston, MA, 5Podiatry, Boston University Medical Center, Boston, MA

    Background/Purpose:   Plantar fasciitis and Achilles tendonitis are commonly encountered in a rheumatologic practice due to either degenerative (DG) or systemic inflammatory conditions (SYS).  While…
  • Abstract Number: 110 • 2014 ACR/ARHP Annual Meeting

    Use of Smartphones in Collecting Patient Reported Outcomes: Can Passively-Collected Behavior Determine Rheumatic Disease Activity? Early Results from a Nation-Wide Pilot Study

    Kaleb Michaud1,2, Sofia Pedro1, Rebecca Schumacher1, Karim Wahba3 and Sai Moturu3, 1National Data Bank for Rheumatic Diseases, Wichita, KS, 2Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 3ginger.io, San Francisco, CA

    Background/Purpose Rheumatoid arthritis (RA) and other rheumatic diseases (RD) are associated with depression, fatigue, and disturbed sleep, symptoms that often impact behavior. Many smartphone apps…
  • Abstract Number: 3013 • 2014 ACR/ARHP Annual Meeting

    The Reserve Capacity Model in Patients with Rheumatoid Arthritis: Understanding the Relationship of Socioeconomic Status, Psychosocial Resources, Mood, and Pain

    Desiree Azizoddin1,2, Taylor Draper1,2, Sarah Ormseth3, Perry M. Nicassio4, Michael R. Irwin4, Michael Weisman5 and Hilary Wilson2, 1Psychology, Loma Linda University, Loma Linda, CA, 2Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA, 3University of California, Los Angeles, Los Angeles, CA, 4Cousins Center for PNI, University of California, Los Angeles, Los Angeles, CA, 5Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA

    The Reserve Capacity Model in Patients with Rheumatoid Arthritis: Understanding the Relationship of Socioeconomic Status, Psychosocial Resources, Mood, and Pain. Background/Purpose: The reserve capacity model…
  • Abstract Number: 109 • 2014 ACR/ARHP Annual Meeting

    Knee Arthroscopy in an International Training Centre: An Audit of Safety and Impact on Work Days

    Carl Orr1, Paul MacMullan1, Phil Gallagher2, Mairead Murray1, Madeline O'Neill1 and Douglas J. Veale3, 1Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 2Rheumatology, St. Vincent's University Hospital, Dublin, Ireland, 3Translational Rheumatology Research Group, St. Vincent's University Hospital, Dublin 4, Ireland

    Background/Purpose The utility of synovial biopsy has been confirmed as an important research tool in increasing our understanding of the pathogenesis of RA, evaluating new…
  • Abstract Number: 2967 • 2014 ACR/ARHP Annual Meeting

    Patient Reported Pain By the Paindetect Questionnaire Reveals Multimodal Elements to Pain Perception in Rheumatoid Arthritis

    Saqa Ahmed1, Tejal Magan1, Mario Vargas1, Abiola Harrison1 and Nidhi Sofat2, 1Rheumatology, Mailpoint J1A, St George's, University of London, London, United Kingdom, 2Rheumatology, St. George's University of London, London, United Kingdom

    Background/Purpose: Rheumatoid arthritis (RA) is an inflammatory autoimmune condition typified by systemic inflammation targeted towards synovial joints. Inhibition of pro-inflammatory networks by disease-modifying anti-rheumatic drugs…
  • Abstract Number: 71 • 2014 ACR/ARHP Annual Meeting

    Prevalence of Pain Reporting in Different Ethnic Groups in the UK: Results from a Large Biobank

    Marcus Beasley1, Gareth T. Jones1, Tatiana Macfarlane2 and Gary J. Macfarlane1, 1Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 2Dental School, University of Aberdeen, Aberdeen, United Kingdom

    Background/Purpose: Very large epidemiological studies designed to investigate genetic and environmental influences on disease, known as ‘biobanks' can be used to look at associations between…
  • Abstract Number: 2416 • 2014 ACR/ARHP Annual Meeting

    Do Patterns of Joint Swelling or Tenderness in Rheumatoid Arthritis Patients Impact Disease Activity Outcomes and Pain?  Implications for Clinical Practice

    Regan Arendse1, John Kelsall2, J. Antonio Avina-Zubieta3, Philip Baer4, Erica Weinberg4, Jude Rodrigues5, Algis Jovaisas6, Isabelle Fortin7, Maqbool Sheriff8, Majed M. Khraishi9, Emmanouil Rampakakis10, John S. Sampalis10, Francois Nantel11, Susan Otawa12 and Allen J Lehman12, 1University of Saskatchewan, Saskatoon, SK, Canada, 2The Mary Pack Arthritis Centre, Vancouver, BC, Canada, 3Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Private Practice, Scarborough, ON, Canada, 5Clinical Research and Arthritis Centre, Windsor, ON, Canada, 6194 Main Street, University of Ottawa, Ottawa, ON, Canada, 7Centre de Rhumatologie de l'Est du Québec, Rimouski, QC, Canada, 8Nanaimo Regional General Hospital, Nanaimo, BC, Canada, 9Nexus Clinical Research, Memorial University of Newfoundland, St Johns, NF, Canada, 10JSS Medical Research, Montreal, QC, Canada, 11Janssen Inc., Toronto, ON, Canada, 12Medical Affairs, Janssen Inc., Toronto, ON, Canada

    Background/Purpose This analysis aimed to describe the pattern of specific joint involvement (tender and/or swollen) pre- and post-TNFi treatment and the impact of specific joint…
  • Abstract Number: 1482 • 2014 ACR/ARHP Annual Meeting

    Response of Patient Reported Symptoms of Stiffness and Pain during the Day from Adding Low-Dose Delayed-Release (DR) Prednisone to Stable DMARD Therapy over 12 Weeks in Patients with Moderate Rheumatoid Arthritis (RA)

    Rieke Alten1, Amy Y. Grahn2, Patricia Rice3, Robert Holt4 and Frank Buttgereit5, 1Charité University Medicine, Berlin, Germany, 2Horizon Pharma, Inc., Deerfield, IL, 3Premier Research, Naperville, IL, 4College of Pharmacy, University of Illinois-Chicago, Vernon Hill, IL, 5Charité University Hospital, Berlin, Germany

     Background/Purpose: RA patients experience stiffness which impacts their daily lives.  Although this patient reported symptom was dropped from the RA classification criteria there is growing…
  • Abstract Number: 1368 • 2014 ACR/ARHP Annual Meeting

    Are Tender Joints Better Than Synovitis to Predict Structural Damage in Rheumatoid Arthritis?

    Peter Cheung1, Karine Mari2, Valerie Devauchelle3, Jacques Bentin4, Sandrine Jousse-Joulin5, Maria-Antonietta d'Agostino6, Gérard Chales7, Isabelle Chary-Valckenaere8, Fabien Etchepare9, Philippe Gaudin10, Xavier Mariette11, Alain Saraux12 and Maxime Dougados13, 1Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, 2RCT, Lyon, France, 3Rheumatology, Brest university medical school, EA 2216, Lab Ex, INSERM, IGO,UBO and CHU de la Cavale Blanche,, Brest, France, 4Rheumatology, CHU-Brugmann, Brussels, Belgium, 5Rheumatology, CHU Brest, Brest, France, 6Rheumatology, Versailles-Saint Quentin en Yvelines University, Boulogne-Billancourt, France, 7Dept of Rheumatology, CHR - Hopital Sud, Rennes, France, 8Rheumatology, Nancy University Hospital, Nancy, France, 9AP-HP, La Pitié-Salpétrière Hospital, Rheumatology Department, Paris-VI University, Paris, France, 10Rhumatologie, Hopital Sud Grenoble, Echirolles, France, 11Paris-Sud University, Paris, France, 12Rhumatologie, CHU Brest and EA 2216, UBO, Brest, France, 13Université Paris René Descartes and Hôpital Cochin, Paris, France

    Background/Purpose: Longitudinal studies indicate that synovitis can predict subsequent structural damage in rheumatoid arthritis (RA) but the clinical relevance of tenderness is unclear. The aim…
  • Abstract Number: 1330 • 2014 ACR/ARHP Annual Meeting

    The Efficacy of a Multidisciplinary Intervention Strategy for the Treatment of Benign Joint Hypermobility Syndrome (BJHS) in Childhood: A Randomized, Single Center Parallel Group Trial

    Peter Bale1, Vicky Easton2, Holly Bacon2, Emma Jerman3, Kate Armon4 and Alex J Macgregor1,5, 1School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, United Kingdom, 2Paediatric Physiotherapy Department, Norfolk and Norwich University Hospital, Norwich, United Kingdom, 3Occupational Therapist, Norwich, United Kingdom, 4Paediatric Rheumatology, Jenny Lind Children's Hospital, Norfolk and Norwich University Hospital, Norwich, United Kingdom, 5Rheumatology, Norfolk and Norwich University Hospital, Norwich, United Kingdom

    Background/Purpose: Joint hypermobility is common in childhood and can be associated with musculoskeletal pain and dysfunction.  Current management is delivered by a multidisciplinary team but…
  • Abstract Number: 1111 • 2014 ACR/ARHP Annual Meeting

    The Effect of High Intensity Laser Therapy in the Management of Myofascial Pain Syndrome of the Trapezius: A Double Blind, Placebo-Controlled Study

    Umit Dundar, Utku Turkmen, Hasan Toktas, Ozlem Solak and Alper Ulasli, Department of Physical Medicine and Rehabilitation, Afyon Kocatepe University, Faculty of Medicine, Afyonkarahisar, Turkey

    The effect of high intensity laser therapy in the management of myofascial pain syndrome of the trapezius: a double blind, placebo-controlled studyAbstractBackground/Purpose: Myofascial pain syndrome…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology